Third Annual UT Southwestern Multidisciplinary Endocrine Tumor Symposium (RP2309B)

September 8, 2023

This live virtual CME event is designed for physicians, APPs, nurses, and other healthcare professionals in the fields of internal medicine, family practice, endocrinology, nephrology, and surgery. Didactic presentations by world renowned experts in the area will provide a comprehensive review of the biochemical evaluation and therapeutic considerations for hyperparathyroidism. Case presentations will provide practical lessons in interpreting complete biochemical data and applying current therapeutic guidelines.

Target Audience

Physicians, APPs, nurses, and other healthcare professionals in the fields of internal medicine, family practice, endocrinology, nephrology, and surgery. 

Learning Objectives

Professional practice gap:

The biochemical diagnosis of primary hyperparathyroidism can be challenging in the setting of subtle lab abnormalities and confounding factors. Thus, making an appropriate biochemical diagnosis has a significant impact on evidence based therapeutic recommendations and resource utilization. Patients with parathyroid diagnoses may see physicians in different specialties with incongruent recommendations.


Educational Need:

Greater knowledge of what constitutes a complete biochemical evaluation of hyperparathyroidism and recognize therapeutic considerations for individual patients.


Learning objectives:

Identify patients with primary hyperparathyroidism.

Assess benefits of hyperparathyroidism surgery.

Recognize medical management strategies.


Desired Result:

Optimal medical and surgical evaluations to promote evidence-based patient care.

Additional Information

File RP2309B_CME-Handout (1).docx81.43 KB
Course summary
Available credit: 
  • 2.50 AMA
  • 2.50 Attendance
Course opens: 
Course expires: 
Event starts: 
09/08/2023 - 1:00pm CDT
Event ends: 
09/08/2023 - 4:00pm CDT



AGENDA (click on presentation title to view slide in pdf format)

1:00-1:05 PM       Welcome / Introductions

1:05-1:40 PM       Biochemical evaluation of hyperparathyroidism: What to order, how to interpret results                                                                                           Invited Speaker:  Dr. Robert Wermers

1:50-2:00 PM      Q&A

2:00-2:25 PM      Case Discussion: Diagnostic considerations in hyperparathyroidism

2:25-2:35 PM       Break

2:35-3:20 PM       Therapeutic considerations in primary hyperparathyroidism: I made the diagnosis, now what?                                                                                  Invited Speaker:  Dr. John Bilezikian

3:20-3:30 PM       Q&A

3:30-4:00 PM      Case discussion: Therapeutic considerations in primary hyperparathyroidism

4:00 PM               Adjourn                        

UT Southwestern Medical Center
Dallas, TX
United States


The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation 

The University of Texas Southwestern Medical Center designates this continuing education activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for a maximum of 2.5 AMA PRA Category 1 Credits™.

Available Credit

  • 2.50 AMA
  • 2.50 Attendance


Please login or create an account to take this course.